If you purchased Toprol XL, the heart medication, you may be eligible for a class action award. A settlement has been reached in a case where defendants were alleged to have used patent filings and lawsuits against its competitors to stop them from selling a low-cost generic version of their prescription drug, Toprol XL, violating U.S. Antitrust laws.
This settlement benefits both consumers and third party payors, like insurance companies. You can find the claim form today in our new Pharmaceutical Products Section of our Eligibility Guide.
The amount of the award will be based on how much you paid for Toprol XL or generic metoprolol succinate and when you paid it, as well as on how much was paid by other Class Members who file valid claims, and when they paid it.
The deadline to file a claim is April 1, 2013.